RO5036505

RO5036505 · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO5036505, covering 2016-08-24 to 2016-08-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO5036505 in Patients With Moderate to Severe Asthma [Phase 2]